 OXNARD, Calif.--BUSINESS WIRE--- CURR CBD--CURE Pharmaceutical Holdings CURE or the Company OTC: CURR, a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors. After a dedicated run as Chairman of the Board, William Yuan is stepping down and will continue to serve the Company as an advisor and Chairman Emeritus. Rubén José King-Shaw Jr, a highly qualified and respected member of 